Foreign Legal Consultant Andres Alvarez was quoted in a Texas Lawbook article, “Call Me By My Name: And No, I’m Not NAFTA,” about the status of the new free trade agreement between the U.S, Canada and Mexico and how it might affect businesses that have grown accustomed to dealing with NAFTA.
Alvarez, a panelist at a program called “The New NAFTA: Getting Down to Business,” said some of the most sweeping changes are likely to be felt in the auto industry, where new requirements for parts origination and a raise in salary standards are likely to have a dramatic effect. “I think that probably cars will get more expensive,” he said. “Whether that’s good or not, the bottom line will be a matter of cost/benefit analysis.”
Subscription required.
Alvarez, a panelist at a program called “The New NAFTA: Getting Down to Business,” said some of the most sweeping changes are likely to be felt in the auto industry, where new requirements for parts origination and a raise in salary standards are likely to have a dramatic effect. “I think that probably cars will get more expensive,” he said. “Whether that’s good or not, the bottom line will be a matter of cost/benefit analysis.”
Subscription required.
People
Related News
July 24, 2025
In the News
Foley's Trial Team Featured Following Landmark Victory in Texas Trade Secret Case
Foley & Lardner LLP’s recent landmark appellate victory in a Texas trade secrets case is featured in the Texas Lawyer article, "Ruling Sets Precedent for Employment, Trade Secrets, Fiduciary Duty."
July 24, 2025
In the News
Gregory Husisian and David Simon on Tariff Evasion – 'Huge money at stake'
Foley & Lardner LLP partners Gregory Husisian and David Simon detailed the rise and risks of tariff evasion in the POLITICO article, "As Trump raises tariffs, companies find ways to cheat — and risk getting caught."
July 23, 2025
In the News
Aaron Maguregui on AI Scribes in Health Care – 'Technically, it's a third party listening'
Foley & Lardner LLP partner Aaron Maguregui shared insights on the growing applications for artificial intelligence across health care in the healthleaders article, “Is Your AI Scribe HIPAA-Compliant?“